Update on geriatric cardiology;Actualización en cardiología geriátrica

Revista Espanola de Cardiologia

Volumn 62, Issue SUPPL. 1, 2009, Pages 53-66

  Martínez Sellés, Manuel ^a   López Palop, Ramón ^b   Datino, Tomás ^a   Bañuelos, Camino ^c  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Elderly; Geriatric cardiology; Heart disease

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; CAPTOPRIL; CLOPIDOGREL; DRONEDARONE; ENALAPRIL; ENOXAPARIN; FIBRINOGEN RECEPTOR; FOSINOPRIL; HEPARIN; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LISINOPRIL; LOW DENSITY LIPOPROTEIN; PLACEBO; QUINAPRIL; RAMIPRIL; RAPAMYCIN; ROSUVASTATIN;

AORTA VALVE DISEASE; CARDIOLOGY; CARDIOVASCULAR RISK; CLINICAL TRIAL; DEFIBRILLATOR; DEMENTIA; GERIATRICS; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART FIBRILLATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; IMPLANTATION; ISCHEMIC HEART DISEASE; MORTALITY; PROGNOSIS; REVIEW; SINUS RHYTHM; SPAIN; ST SEGMENT ELEVATION; STABLE ANGINA PECTORIS; STENT; SUDDEN DEATH; THROMBOEMBOLISM; TREATMENT INDICATION;

EID: 61849172976     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(09)70041-7     Document Type: Article

References (84)

1. L. Liao, L.A. Allen, and D.J. Whellan Economic burden of heart failure in the elderly Pharmacoeconomics 26 2008 447 462
2. L.H. Curtis, D.J. Whellan, B.G. Hammill, A.F. Hernandez, K.J. Anstrom, and A.M. Shea Incidence and prevalence of heart failure in elderly persons, 1994-2003 Arch Intern Med 168 2008 418 424
3. H. Mahjoub, D. Rusinaru, V. Soulière, C. Durier, M. Peltier, and C. Tribouilloy Long-term survival in patients older than 80 years hospitalised for heart failure. A 5-year prospective study Eur J Heart Fail 10 2008 78 84
4. L. Pérez de Isla, V. Cañadas, L. Contreras, C. Almería, J.L. Rodrigo, and A.L. Aubele Diastolic heart failure in the elderly: In-hospital and long-term outcome after the first episode Int J Cardiol 2008 Mar 18 [Epub ahead of print]
5. C. Tribouilloy, D. Rusinaru, H. Mahjoub, V. Soulière, F. Lévy, and M. Peltier Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study Eur Heart J 29 2008 339 347
6. R. Valle, C. Prevaldi, A. D'Eri, A. Fontebasso, P. Giovinazzo, and F. Noventa B-type natriuretic peptide predicts postdischarge prognosis in elderly patients admitted due to cardiogenic pulmonary edema Am J Geriatr Cardiol 15 2006 202 207
7. M. Cournot, F. Mourre, F. Castel, J. Ferrières, and S. Destrac Optimization of the use of B-type natriuretic peptide levels for risk stratification at discharge in elderly patients with decompensated heart failure Am Heart J 155 2008 986 991
8. M. Cournot, P. Leprince, S. Destrac, and J. Ferrières Usefulness of in-hospital change in B-type natriuretic peptide levels in predicting long-term outcome in elderly patients admitted for decompensated heart failure Am J Geriatr Cardiol 16 2007 8 14
9. A.J. Pelle, Y.Y. Gidron, B.M. Szabó, and J. Denollet Psychological predictors of prognosis in chronic heart failure J Card Fail 14 2008 341 350
10. A. Macchia, S. Monte, F. Pellegrini, M. Romero, A. D'Ettorre, and L. Tavazzi Depression worsens outcomes in elderly patients with heart failure: An analysis of 48,117 patients in a community setting Eur J Heart Fail 10 2008 714 721
11. J. Kjekshus, E. Apetrei, V. Barrios, M. Böhm, J.G. Cleland, J.H. Cornel CORONA Group Rosuvastatin in older patients with systolic heart failure N Engl J Med 357 2007 2248 2261
12. S. Rinfret, H. Behlouli, M.J. Eisenberg, K. Humphries, J.V. Tu, and L. Pilote Class effects of statins in elderly patients with congestive heart failure: a population-based analysis Am Heart J 155 2008 316 323
13. R. Shah, Y. Wang, and J.M. Foody Effect of statins, angiotensinconverting enzyme inhibitors, and beta blockers on survival in patients >or= 65 years of age with heart failure and preserved left ventricular systolic function Am J Cardiol 101 2008 217 222
14. M. Martínez-Sellés, M. Domínguez, E. Martínez, M.A. García Fernández, and E. García Statin use and prognosis in patients with advanced heart failure Int J Cardiol 118 2007 135 137
15. L. Tavazzi, G. Tognoni, M.G. Franzosi, R. Latini, A.P. Maggioni, and R. Marchioli GISSI-HF Investigators. Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure Eur J Heart Fail 6 2004 635 641
16. L. Pilote, M. Abrahamowicz, M. Eisenberg, K. Humphries, H. Behlouli, and J.V. Tu Effect of different angiotensin-convertingenzyme inhibitors on mortality among elderly patients with congestive heart failure CMAJ 178 2008 1303 1311
17. L. Pilote, M. Abrahamowicz, E. Rodrigues, M.J. Eisenberg, and E. Rahme Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: a class effect? Ann Intern Med 141 2004 102 112
18. M. Martínez-Sellés, J.A. García Robles, R. Muñoz, J.A. Serrano, E. Frades, and M. Domínguez Muñoa Pharmacological treatment in patients with heart failure: patients knowledge and occurrence of polypharmacy, alternative medicine and immunizations Eur J Heart Fail 6 2004 219 226
19. T.S. Rector, I.S. Anand, D.B. Nelson, and K.E. Ensrud Carvedilol versus controlled-release metoprolol for elderly veterans with heart failure J Am Geriatr Soc 56 2008 1021 1027
20. H.D. Düngen, F. Mehrhof, S. Apostolovic, S. Inkrot, and R. Dietz Beta-blocker tolerability in elderly heart failure patients Int J Cardiol 2008 Jul 3 [Epub ahead of print]
21. H.D. Düngen, S. Apostolovic, S. Inkrot, E. Tahirovic, F. Krackhardt, M. Pavlovic On behalf of the CIBIS-ELD investigators, subproject "Multicenter Trials" in the Competence Network Heart Failure Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial Clin Res Cardiol 97 2008 578 586 2008 Jun 9 [Epub ahead of print]
22. M. Martínez-Sellés, T. Datino, M. Alhama, N. Barrueco, I. Castillo, and F. Fernández-Avilés Rapid carvedilol up-titration in hospitalized patients with systolic heart failure J Heart Lung Transplant 27 2008 914 916
23. G.W. Yip, M. Wang, T. Wang, S. Chan, J.W. Fung, and L. Yeung The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction Heart 94 2008 573 580
24. D.A. Sica, T.W. Gehr, and W.H. Frishman Use of diuretics in the treatment of heart failure in the elderly Clin Geriatr Med 23 2007 107 121
25. P.P. Delnoy, J.P. Ottervanger, H.O. Luttikhuis, A. Elvan, A.R. Misier, and W.P. Beukema Clinical response of cardiac resynchronization therapy in the elderly Am Heart J 155 2008 746 751
26. R. Coma-Samartín, J. Martínez-Ferrer, M.J. Sancho-Tello de Carranza, F. Ruiz-Mateas, and J. Leal Del Ojo-González Registro Español de Marcapasos. IV Informe Oficial de la Sección de Estimulación Cardiaca de la Sociedad Española de Cardiología (2006) Rev Esp Cardiol 60 2007 1302 1313
27. R. Peinado, E.G. Torrecilla, J. Ormaetxe, M. Álvarez Grupo de Trabajo de Desfibrilador Implantable Registro Español de Desfibrilador Automático Implantable. III Informe Oficial del Grupo de Trabajo de Desfibrilador Automático Implantable de la Sociedad Española de Cardiología (2006) Rev Esp Cardiol 60 2007 1290 1301
28. A. Bowling Honour your father and mother: ageism in medicine Br J Gen Pract 57 2007 347 348
29. H. Calkins, J. Brugada, D.L. Packer, R. Cappato, S.A. Chen, and H.J. Crijns HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up Europace 9 2007 335 379
30. E. Zado, D.J. Callans, M. Riley, M. Hutchinson, F. Garcia, and R. Bala Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in the elderly J Cardiovasc Electrophysiol 19 2008 621 626
31. A. Corrado, D. Patel, L. Riedlbauchova, T.S. Fahmy, S. Themistoclakis, and A. Bonso Efficacy, safety, and outcome of atrial fibrillation ablation in septuagenarians J Cardiovasc Electrophysiol 19 2008 807 811
32. V. Fuster, L.E. Ryden, D.S. Cannom, H.J. Crijns, A.B. Curtis, and K.A. Ellenbogen ACC/AHA/ESC: Guía de práctica clínica 2006 para el manejo de pacientes con fibrilación auricular. Versión resumida Rev Esp Cardiol 59 2006 1329.e1 1329.e64
33. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
34. O.M. Ruiz, E. Romo, D. Mesa, M. Delgado, M. Anguita, and G.A. Lopez Predicción de eventos embólicos en pacientes con fibrilación auricular no valvular: evaluación del score CHADS2 en una población mediterránea Rev Esp Cardiol 61 2008 29 35
35. D. Poli, E. Antonucci, R. Marcucci, C. Fatini, B. Alterini, and L. Mannini Risk of bleeding in very old atrial fibrillation patients on warfarin: relationship with ageing and CHADS2 score Thromb Res 121 2007 347 352
36. M. Martínez-Sellés, T. Datino, M.A. Gómez Sánchez, and C. Bañuelos Actualización en cardiología geriátrica Rev Esp Cardiol 61 Supl 1 2008 4 14
37. Hohnloser SH. A placebo-controlled, double-blind, parallel arm trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter (AF/AFL). San Francisco: Heart Rhythm Society 2008 Scientific Sessions.
38. B.N. Singh, S.J. Connolly, H.J. Crijns, D. Roy, P.R. Kowey, and A. Capucci Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter N Engl J Med 357 2007 987 999
39. L. Kober, C. Torp-Pedersen, J.J. McMurray, O. Gotzsche, S. Levy, and H. Crijns Increased mortality after dronedarone therapy for severe heart failure N Engl J Med 358 2008 2678 2687
40. D. Roy, M. Talajic, S. Nattel, D.G. Wyse, P. Dorian, and K.L. Lee Rhythm control versus rate control for atrial fibrillation and heart failure N Engl J Med 358 2008 2667 2677
41. D.G. Wyse, A.L. Waldo, J.P. DiMarco, M.J. Domanski, Y. Rosenberg, and E.B. Schron A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833
42. Y. Miyasaka, M.E. Barnes, R.C. Petersen, S.S. Cha, K.R. Bailey, and B.J. Gersh Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohort Eur Heart J 28 2007 1962 1967
43. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen, N.A. Estes III, R.A. Freedman, and L.S. Gettes ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation 117 2008 e350 408e
44. D.P. Zipes, A.J. Camm, M. Borggrefe, A.E. Buxton, B. Chaitman, and M. Fromer Guías de Práctica Clínica del ACC/AHA/ESC 2006 sobre el manejo de pacientes con arritmias ventriculares y la prevención de la muerte cardiaca súbita. Versión resumida Rev Esp Cardiol 59 2006 1328.e1 1328.e51
45. P.S. Mueller, S.M. Jenkins, K.A. Bramstedt, and D.L. Hayes Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes Pacing Clin Electrophysiol 31 2008 560 568
46. P.W. Groeneveld, S.A. Farmer, J.J. Suh, M.A. Matta, and F. Yang Outcomes and costs of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death among the elderly Heart Rhythm 55 2008 646 653
47. D.W. Brown, J.B. Croft, K.J. Greenlund, G.A. Mensah, and W.H. Giles Trends in hospitalization for the implantation of cardioverter-defibrillators in the United States, 1990-2005 Am J Cardiol 101 2008 1753 1755
48. G. Lin, R.A. Meverden, D.O. Hodge, D.Z. Uslan, D.L. Hayes, and P.A. Brady Age and gender trends in implantable cardioverter defibrillator utilization: a population based study J Interv Card Electrophysiol 22 2008 65 70
49. V.Y. Reddy, M.R. Reynolds, P. Neuzil, A.W. Richardson, M. Taborsky, and K. Jongnarangsin Prophylactic catheter ablation for the prevention of defibrillator therapy N Engl J Med 357 2007 2657 2665
50. T.D. Fraker, S.D. Fihn, R.J. Gibbons, J. Abrams, K. Chatterjee, and J. Daley 2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 Guidelines for the management of patients with chronic stable angina Circulation 116 2007 2762 2772
51. E.M. Antman, M. Hand, P.W. Armstrong, E.R. Bates, L.A. Green, and L.K. Halasyamani 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 51 2008 210 247
52. M.E. Pfisterer, M. Buser, G.M. Kuster, L. Grize, and P.T. Buser Improvements in physical and mental domains of quality of life by antiischemic drug and revascularization therapy in elderly men and women with chronic angina Heart 2008 Jan 20 [Epub ahead of print]
53. J. Afilalo, G. Duque, R. Steele, J.W. Jukema, A.J. De Craen, and M.J. Eisenberg Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis J Am Coll Cardiol 51 2008 37 45
54. G. Devlin, J.M. Gore, J. Elliott, N. Wijesinghe, K.A. Eagle, and A. Avezum Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary Events Eur Heart J 29 2008 1275 1282
55. C.J. Vrints Acute coronary syndrome in the elderly Eur Heart J 29 2008 1213 1214
56. S.M. Tahir, L.L. Price, P.B. Shah, and F.G. Welt Eighteen year (1985-2002) analysis of incidence, mortality, and cardiac procedure outcomes of acute myocardial infarction in patients > or = 65 years of age Am J Cardiol 101 2008 930 936
57. R.D. Lopes, K.P. Alexander, G. Marcucci, H.D. White, S. Spinler, and J. Col Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial Eur Heart J 29 2008 1827 1833
58. K.A. Eagle, B.K. Nallamothu, R.H. Mehta, C.B. Granger, P.G. Steg, and W.F. Van de Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go Eur Heart J 29 2008 609 617
59. E.L. Fosbol, J.J. Thune, H. Kelbaeaek, H.R. Andersen, K. Saunamaaki, and T.T. Nielsen Long-term outcome of primary angioplasty compared with fibrinolysis across age groups: a Danish Multicenter Randomized Study on Fibrinolytic Therapy Versus Acute Coronary Angioplasty in Acute Myocardial Infarction (DANAMI-2) substudy Am Heart J 156 2008 391 396
60. P. Wenaweser, M. Ramser, S. Windecker, I. Lutolf, B. Meier, and C. Seiler Outcome of elderly patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction Catheter Cardiovasc Interv 70 2007 485 490
61. A. Hovanesyan, and M.W. Rich Outcomes of acute myocardial infarction in nonagenarians Am J Cardiol 101 2008 1379 1383
62. S. Setoguchi, R.J. Glynn, J. Avorn, M.A. Mittleman, R. Levin, and W.C. Winkelmayer Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis J Am Coll Cardiol 51 2008 1247 1254
63. D.S. Likosky, L.J. Dacey, Y.R. Baribeau, B.J. Leavitt, R. Clough, and R.P. Cochran Long-term survival of the very elderly undergoing coronary artery bypass grafting Ann Thorac Surg 85 2008 1233 1237
64. L.J. Dacey, D.S. Likosky, T.J. Ryan, J.F. Robb, R.D. Quinn, and J.T. DeVries Long-term survival after surgery versus percutaneous intervention in octogenarians with multivessel coronary disease Ann Thorac Surg 84 2007 1904 1911
65. T. Palmerini, F. Barlocco, A. Santarelli, L. Bacchi-Reggiani, C. Savini, and E. Baldini A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged > or =75 years) Eur Heart J 28 2007 2714 2719
66. M. Singh, B.J. Gersh, S. Li, J.S. Rumsfeld, J.A. Spertus, and S.M. O'Brien Mayo Clinic Risk Score for percutaneous coronary intervention predicts in-hospital mortality in patients undergoing coronary artery bypass graft surgery Circulation 117 2008 356 362
67. H.H. Ting, M.T. Roe, B.J. Gersh, J.A. Spertus, J.S. Rumsfeld, and F.S. Ou Factors associated with off-label use of drug-eluting stents in patients with ST-elevation myocardial infarction Am J Cardiol 101 2008 286 292
68. M. Wiemer, C. Langer, T. Kottmann, D. Horstkotte, C. Hamm, and T.H. Pfannebecker Outcome in the elderly undergoing percutaneous coronary intervention with sirolimus-eluting stents: results from the prospective multicenter German Cypher Stent Registry Am Heart J 154 2007 682 687
69. P.J. Vlaar, R.J. Lennon, C.S. Rihal, M. Singh, H.H. Ting, and J.F. Bresnahan Drug-eluting stents in octogenarians: early and intermediate outcome Am Heart J 155 2008 680 686
70. P.W. Groeneveld, M.A. Matta, A.P. Greenhut, and F. Yang Drugeluting compared with bare-metal coronary stents among elderly patients J Am Coll Cardiol 51 2008 2017 2024
71. R.O. Bonow, B.A. Carabello, C. Kanu, A.C. De Leon Jr, D.P. Faxon, and M.D. Freed ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons Circulation 114 2006 e84 e231
72. B. Iung, G. Baron, E.G. Butchart, F. Delahaye, C. Gohlke-Bärwolf, and O.W. Levang A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease Eur Heart J 24 2003 1231 1243
73. P. Varadarajan, N. Kapoor, R.C. Bansal, and R.G. Pai Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis Ann Thorac Surg 82 2006 2111 2115
74. R.G. Pai, N. Kapoor, R.C. Bansal, and P. Varadarajan Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement Ann Thorac Surg 82 2006 2116 2122
75. C.M. Otto Valvular heart disease: focus on women Cardiol Rev 15 2007 291 297
76. M.J. Antunes Percutaneous aortic valve implantation. The demise of classical aortic valve replacement? Eur Heart J 29 2008 1339 1341
77. A. Cribier, H. Eltchaninoff, A. Bash, N. Borenstein, C. Tron, and F. Bauer Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description Circulation 106 2002 3006 3008
78. A. Vahanian, O. Alfieri, N. Al-Attar, M. Antunes, J. Bax, and B. Cormier European Association of Cardio-Thoracic Surgery; European Society of Cardiology; European Association of Percutaneous Cardiovascular Interventions. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur Heart J 29 2008 1463 1470
79. F. Descoutures, D. Himbert, L. Lepage, B. Iung, D. Détaint, and D. Tchetche Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly Eur Heart J 29 2008 1410 1417
80. C.E. Ruiz, J.C. Laborde, J.F. Condado, P.T. Chiam, and J.A. Condado First percutaneous transcatheter aortic valve-in-valve implant with three year follow-up Catheter Cardiovasc Interv 72 2008 143 148
81. R. Quaden, T. Attmann, M. Schünke, D. Theisen-Kunde, J. Cremer, and G. Lutter Percutaneous aortic valve replacement: endovascular resection of human aortic valves in situ J Thorac Cardiovasc Surg 135 2008 1081 1086
82. P.T. Chiam, R. Del Valle-Fernández, and C.E. Ruiz Terapéutica valvular percutánea Rev Esp Cardiol 61 Supl 2 2008 10 24
83. A. Agarwal, A.S. Kini, S. Attanti, P.C. Lee, R. Ashtiani, and A.M. Steinheimer Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59 to 104 years Am J Cardiol 95 2005 43 47
84. H. Hara, W.R. Pedersen, E. Ladich, M. Mooney, R. Virmani, and M. Nakamura Percutaneous balloon aortic valvuloplasty revisited: time for a renaissance? Circulation 115 2007 e334 e338